Provention Bio | Investor Relations - News
Our Team | Sanofi Ventures
People Moves EMEA: Deloitte, Oliver Wyman, Bain, Citi | Business Chief EMEA
Sanofi makes $3.2B bet on mRNA by acquiring partner Translate Bio - Boston Business Journal
Media Contacts - Sanofi
Sanofi revises fitusiran dosing to cut risk of thrombotic events in hemophilia phase 3 | Fierce Biotech
Sanofi Goes Big with $1 Billion Immuno-Oncology Buy | BioSpace
Media Contacts - Sanofi
Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Press Release: Sanofi and Innate Pharma expand
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D) - Sanofi
Sanofi's emerging oncology pipeline highlighted at the AACR Virtual Annual Meeting II
Media Contacts - Sanofi
Sally Whiting Bain (@sbain09) / Twitter
Anthony Jones - Bain External Advisor - Bain & Company | LinkedIn
Bain Capital buys majority stake in Rural Sourcing - Atlanta Business Chronicle
